FEATURED COMPANIES

The average age of women giving birth in United States has increased over the years. It’s no longer unusual for women to have a first child at age 35 or even 40. This trend has been attributed to numerous factors such as recession and associated affordability issues, and women being more focused on their careers than before. However, increased age of the mother also increases the risk of her child developing chromosomal abnormalities. This risk has thus paved the way for NIPT tests which have emerged as the next big thing in the field of prenatal diagnostics.

According to our report, “US Non-Invasive Prenatal Testing Market Outlook 2018”, the rise in high risk births has been contributing to the growth of the NIPT market which is anticipated to grow at a CAGR of over 20% for the next 5 years. Our report provides a detailed insight into the current scenario and future outlook of the US NIPT. This market’s potential and the actual market have been deduced and it has been inferred that 2/3 rd of the total market remains untapped. Contribution of every NIPT player has also been provided in terms of current and future market shares.

The demographic scenario
of United States has been discussed with focus on the current and future number of births, with the demographics segregated by age and state. Although, the market has witnessed stupendous growth and new tests have gained acceptance rapidly, much of it still remains untapped due to various reasons. This has been discussed in the section dedicated to the potential market for 2013 and 2018.

A thorough analysis has been done illustrating the views of regulatory authorities, players and consumers towards regulatory stringency and the direction of regulations in the future have also been covered.

The US NIPT sector is characterized by the presence of players like Sequenom, Verinata, Ariosa and Natera. These players have been profiled with their strengths and weaknesses and latest developments in the field of NIPT. The report, which provides a prudent analysis of the current and future size of the market weighing the possible pessimistic and optimistic scenarios, is a must buy for players planning to enter the prenatal segment.
SHOW LESS
READ MORE >

MAKING A DIFFERENCE

CHARITY PARTNERS

KEEP UP TO DATE

ON ALL THE LATEST PRODUCTS

Enter your email address:

TESTIMONIALS

Thank you very much for the quick report delivery and response for all my requests and inquiries. You and your team worked very efficiently to help me get the report I was looking for.
The on-line purchase process also worked flawlessly and left a very professional and reliable impression to me using your services for the first time – and certainly not the last! Thanks!Dr. Arno AvelaApplication Marketing ManagerBorealis Polymers OY